Cagrilintide

Synonyms: Cagrilintide, 1415456-99-3, Amylin analog, Long-acting amylin analog, NN-9935, Cagrilintide acetate

Cagrilintide is a synthetic analog of human amylin, a peptide hormone that works alongside insulin to regulate postprandial glucose levels and signal satiety. Developed by Novo Nordisk, this long-acting amylin analog is designed for once-weekly dosing, making it a promising candidate for obesity and type 2 diabetes management. Its extended half-life is achieved through fatty acid acylation, which promotes albumin binding and slows renal clearance.

Funktion

• Amylin receptor agonist: Activates amylin receptors, reducing food intake and delaying gastric emptying.
• Appetitregulierung: Enhances satiety signaling, leading to reduced caloric intake.
• Weight management: Promotes weight loss in overweight and obese individuals.
• Glycemic control: Helps regulate postprandial glucose levels.

Quelle und Standardisierung

• Quelle: Synthetic peptide, produced via solid-phase peptide synthesis.
• Standardisierung: Purity ≥98% (HPLC), peptide content 70-90%.
• Formulare: Lyophilized powder, acetate salt.
• Anwendungen: Research on obesity, type 2 diabetes, and metabolic disorders.

Dokumentation und Lieferung

• Mindestbestellmenge: 5 g
• Monatliche Kapazität: 1 kg
• Lieferzeit: 5-10 days after order
• Dokumentation: COA, Sicherheitsdatenblatt, Technisches Datenblatt
• Verpackung: Sealed vials or custom packaging

Angebotsanfrage

• Unsere Adresse: 280 Main Street, Xi’an, Shaanxi, China
• LyvBio GmbH. — E-Mail: info@lyvbio.com